Une hypo-protidémie pouvant expliquer une intoxication par l’imatinib chez un patient atteint de leucémie aiguë lymphoblastique à chromosome Philadelphie positif

Daley, 1990, Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome, Science, 247, 824, 10.1126/science.2406902

Mauro, 2002, STI571: a paradigm of new agents for cancer therapeutics, J Clin Oncol, 20, 325, 10.1200/JCO.2002.20.1.325

Guilhot, 2004, Indications for imatinib mesylate therapy and clinical management, Oncologist, 9, 271, 10.1634/theoncologist.9-3-271

Iketani, 2012, Suicide attempt with an overdose of imatinib, Br J Clin Pharmacol, 74, 890, 10.1111/j.1365-2125.2012.04275.x

Bhargav, 2007, Overdose with 6 400mg of imatinib: is it safe?, Ann Oncol, 18, 1750, 10.1093/annonc/mdm458

Dehours, 2010, Overdose with 16 000mg of imatinib mesylate, Leuk Res, 34, 286, 10.1016/j.leukres.2010.05.005

Druker, 2001, Activity of a specific inhibitor of the BCRABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome, N Engl J Med, 344, 1038, 10.1056/NEJM200104053441402

Druker, 2001, Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia, N Engl J Med, 344, 1031, 10.1056/NEJM200104053441401

Breccia, 2005, Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib, Eur J Haematol, 74, 89, 10.1111/j.1600-0609.2004.00347.x

Barton, 2002, Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia, Am J Hematol, 71, 139, 10.1002/ajh.10186

Goldsby, 2002, Unexpected pleural effusions in 3 pediatric patients treated with STI-571, J Pediatr Hematol Oncol, 24, 694, 10.1097/00043426-200211000-00020

Wang, 2008, Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia, Clin Pharmacol Ther, 83, 258, 10.1038/sj.clpt.6100268